August 2016 Vol. 4 No. 3
Click here to access the digital edition
August 2016 Vol. 4 No. 3
Drugs in pregnancy, lactation, and reproductive health: Standards for prescribers
In June 2015, the FDA updated its recommendations for the labeling of drugs with respect to their use by pregnant…
Editor-in-chief’s message
Dear Colleagues, August is National Breastfeeding Awareness Month. As providers of women’s healthcare, we all know the benefits of breastfeeding for babies…
Hypothyroidism in pregnancy
Thyroid disorders are fairly common in pregnancy, with the most common being hypothyroidism. Undiagnosed or inadequately treated hypothyroidism during pregnancy can have…
Interventions to increase LARC acceptances, with a focus on IUCs
Before reading the article, click here to take the pretest. Long-acting reversible contraceptives, or LARC, are growing in popularity because…
Message from the CEO
As I am sure many of you know, NPWH always strives to provide you with tools and information that you can use…
Recognition and prevention of stroke in women
Stroke is a debilitating event with lifelong implications for patients and their families. The sooner that symptoms of a stroke are recognized…
Sexuality in the aging population: Q&A from a certified sex therapist
The author of the second part of this 2-part series on sexuality in the aging population is a Certified Clinical…
Ten questions patients are being encouraged to ask (are you proactively answering them?)
The communication gap between healthcare providers (HCPs) and patients has been met with its fair share of commentary, research, and…
The Doctor of Nursing Practice for Women’s Health Nurse Practitioners
The National Association of Nurse Practitioners in Women’s Health (NPWH) supports a pragmatic approach for the continuing evolution to the Doctor of Nursing…
The pelvic health and wellness program: A niche clinical entity
In today’s healthcare climate, women’s health nurse practitioners (WHNPs) and other NPs providing healthcare for women are in a unique…
The role of anti-Müllerian hormone in diagnosing and managing PCOS
Because multiple subjective factors can cloud the diagnosis of polycystic ovary syndrome, anti-Müllerian hormone (AMH) level, an objective value, has…
Updated contraception resources from the CDC
The U.S. Medical Eligibility Criteria for Contraceptive Use, 2016 (MEC)1 and the U.S. Selected Practice Recommendations for Contraceptive Use, 2016 (SPR)2 were both released to the public…